CME Group Inc is not a strong buy at the moment for a beginner investor with a long-term horizon. While the company has shown strong financial performance in the latest quarter and has positive growth potential, the technical indicators suggest a neutral to slightly bearish trend. Additionally, the options data reflects bearish sentiment, and there are no immediate catalysts to drive significant upward momentum. A hold position is recommended until clearer bullish signals emerge.
The MACD histogram is negative and expanding, indicating bearish momentum. RSI is neutral at 31.048, and moving averages are converging, suggesting indecision in the market. The stock is trading near its S1 support level of 296.35, with resistance at 305.441. Overall, the technical indicators do not signal a strong buy opportunity.

Strong financial performance in Q4 2025, with revenue up 26.71% YoY, net income up 35.23% YoY, and EPS up 35.00% YoY. Analysts have raised price targets recently, citing growth potential in new initiatives like prediction markets and tokenization.
Recent legislative proposals targeting prediction markets could negatively impact CME's growth in this area. Options data reflects bearish sentiment, and technical indicators suggest a lack of bullish momentum. Analysts have also expressed concerns about muted growth in certain segments like equity index and crypto.
In Q4 2025, CME Group reported a 26.71% YoY increase in revenue, a 35.23% YoY increase in net income, and a 35.00% YoY increase in EPS. These results highlight strong growth trends, supported by elevated trading volumes and new initiatives.
Analyst ratings are mixed. While some firms have raised price targets and maintained Buy ratings, others have downgraded the stock to Hold, citing concerns about muted growth in certain segments. The most recent upgrade was from Erste Group, which upgraded CME to Buy from Hold.